PHI with Gastric and duodenal ulcer
How does this condition affect your private health insurance?
Peptic ulcers are open sores that develop on the inside lining of the stomach (gastric ulcer) or the upper part of the small intestine (duodenal ulcer). They result from an imbalance between aggressive factors (acid, pepsin, H. pylori, NSAIDs) and protective factors (mucus, bicarbonate). Symptoms often include burning stomach pain, especially between meals or at night, which may be relieved by food or antacids. Other signs can be bloating, nausea, vomiting, or dark stools indicating bleeding. Complications like bleeding, perforation, or obstruction can be life-threatening if untreated. Diagnosis usually involves endoscopy and H. pylori testing. Treatment focuses on reducing acid and eradicating H. pylori.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 15%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months; typically 4-8 weeks with treatment.
Duration of Illness (Lifetime)
One-time event if successfully treated and underlying causes are eliminated; chronic or recurrent if causative factors (e.g., H. pylori, NSAID use) persist.
Cost of Treatment (Initial)
Low to moderate, typically several hundred to a few thousand USD/EUR (including diagnosis via endoscopy and medication).
Cost of Treatment (Lifetime)
Moderate to high, depending on recurrence and complications. Can reach tens of thousands USD/EUR with severe complications like surgery for perforation or chronic management.
Mortality Rate
Low (less than 1%) with timely diagnosis and appropriate treatment. Significantly higher (up to 10-20%) in cases of severe complications like perforation or massive hemorrhage without intervention.
Risk of Secondary Damages
Moderate to high. Physical complications include bleeding (most common, ~10-20%), perforation (~1-2%), and obstruction (~1-2%). Psychological impacts may include chronic pain leading to anxiety or depression.
Probability of Full Recovery
High (over 80-90%) with appropriate medical treatment, especially successful H. pylori eradication and cessation of NSAID use.
Underlying Disease Risk
High. Helicobacter pylori infection is present in ~70-90% of duodenal and ~50-70% of gastric ulcers. Regular use of non-steroidal anti-inflammatory drugs (NSAIDs) is another major cause. Less commonly, Zollinger-Ellison syndrome or other rare conditions.